"Despite those developments the fact the market is able to resist to this extent means there is some sun ahead, driven by the fact that in medium term economic activity will accelerate and there is positive news o the vaccine."
Pfizer is formally submitting the application on Friday...the review process is expected to take a few weeks. If approved, the first Americans could receive the vaccine by mid-December.